Keywords: schwarz, pharma, beats, forecasts, sales, profits, down
Schwarz Pharma beats forecasts but sales and profits down
Article | 28 February 2005
German drugmaker Schwarz Pharma saw sales in 2004 drop from 1.4 billion euros ($1.83 billion) to 946.6 million euros, mainly because of the sharp ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
